TRPC1 and breast carcinoma: Therefore, chronic DOX exposure at the predetermined IC50 of native MCF-7 cells is capable of selecting against breast cancer cells with innately elevated TRPC1 expression to produce cellular progeny elaborating depressed TRPC1 expression, proliferative capacity and chemosensitivity.